|

6*Nab-P (d 1,8,15)+6*Cb ( d 1)+6*PD1 (d 1) Clinical Trials

1 actively recruiting trial

Also known as: 6*Albumin-bound paclitaxe (d 1,8,15)+6*Carboplatin ( d 1)+6*Camrelizumab (d 1)

Other1 trial

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.